Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 2500.00 | 1344.63 | 3982.00 | 3879.25 | 1.0265 | 1.0345 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 4238.00 | 3879.25 | 1.0925 | 1.1191 | |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 4347.00 | 3879.25 | 1.1206 | 1.1546 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 2500.00 | 1344.63 | 1316.00 | 3879.25 | 0.3392 | -0.0140 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 4070.00 | 3879.25 | 1.0492 | 1.0638 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 4147.00 | 3879.25 | 1.0690 | 1.0893 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 1200.00 | 3879.25 | 0.3093 | -0.0717 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 4149.00 | 3879.25 | 1.0695 | 1.0899 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3702.00 | 3879.25 | 0.9543 | 0.9397 | |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 2500.00 | 1344.63 | 2696.00 | 3879.25 | 0.6950 | 0.5763 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 3975.00 | 3879.25 | 1.0247 | 1.0322 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 2500.00 | 1344.63 | 3982.00 | 3879.25 | 1.0265 | 1.0345 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 1497.00 | 3879.25 | 0.3859 | 0.0728 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 4040.00 | 3879.25 | 1.0414 | 1.0538 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3316.00 | 3879.25 | 0.8548 | 0.8049 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6767.00 | 7393.25 | 0.9153 | 0.9338 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7076.00 | 7393.25 | 0.9571 | 0.9669 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 5000.00 | 1193.65 | 7176.00 | 7393.25 | 0.9706 | 0.9775 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 5000.00 | 1193.65 | 6969.00 | 7393.25 | 0.9426 | 0.9556 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 6737.00 | 7393.25 | 0.9112 | 0.9306 |
| BT-20 | Erlotinib | 1 | uM | 8 | 5000.00 | 1193.65 | 6260.00 | 7393.25 | 0.8467 | 0.8774 |
| BT-20 | Lapatinib | 10 | uM | 8 | 5000.00 | 1193.65 | 3667.00 | 7393.25 | 0.4960 | 0.5321 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 7227.00 | 7393.25 | 0.9775 | 0.9828 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 5000.00 | 1193.65 | 7514.00 | 7393.25 | 1.0163 | 1.0124 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 7420.00 | 7393.25 | 1.0036 | 1.0027 |